Myrianthefs P, Zakynthinos GE, Tsolaki V, Makris D. Aerosolized Antibiotics to Manage Ventilator-Associated Infections: A Comprehensive Review. Antibiotics (Basel, Switzerland), [Internet].2023 [citado 3 de junio del 2023]; 12(5):801. Aviable in: https://doi.org/10.3390/antibiotics12050801

Lu D, Mao W. Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: A systematic review and meta-analysis. Heliyon, [Internet].2023 [citado 3 de junio del 2023], 9(5):e15774. Aviable in: https://doi.org/10.1016/j.heliyon.2023.e15774

Gorham J, Taccone FS, Hites M. How to Use Nebulized Antibiotics in Severe Respiratory Infections. Antibiotics (Basel, Switzerland), [Internet].2023 [citado 3 de junio del 2023], 12(2):267.

Aviable in: https://doi.org/10.3390/antibiotics12020267

De Pascale G, Pintaudi G, Lisi L, De Maio F, Cutuli SL, Tanzarella ES, et al. Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features. Antibiotics (Basel, Switzerland), [Internet].2023 [citado 3 de junio del 2023], 12(1):125.

Aviable in: https://doi.org/10.3390/antibiotics12010125.

Qin JP, Huang HB, Zhou H, Zhu Y, Xu Y, Du B. (2021). Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials. Scientific reports, [Internet].2021 [citado 3 de junio del 2023], 11(1):6969.

Aviable in: https://doi.org/10.1038/s41598-021-86342-8

Lenhard JR, Bulman ZP, Tsuji BT, Kaye KS. Shifting Gears: The Future of Polymyxin Antibiotics. Antibiotics (Basel, Switzerland), [Internet].2019 [citado 3 de junio del 2023] ,8(2):42.

Aviable in: https://doi.org/10.3390/antibiotics8020042

Monsel A, Torres A, Zhu Y, Pugin J, Rello J, Rouby JJ, et al. Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials. Current opinion in infectious diseases, [Internet].2021 [citado 4 de junio del 2023] ,34(2):156–168. Aviable in: https://doi.org/10.1097/QCO.0000000000000720

Zhu Y, Monsel A, Roberts JA, Pontikis K, Mimoz O, Rello J, et al. Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives. Microorganisms, [Internet].2021 [citado 4 de junio del 2023], 9(6):1154.

Aviable in: https://doi.org/10.3390/microorganisms9061154

Rello J, Bouglé A, Rouby JJ. Aerosolised antibiotics in critical care. Intensive care medicine, [Internet].2023 [citado 4 de junio del 2023]. Advance online publication. Aviable in: https://doi.org/10.1007/s00134-023-07036-5

Rouby JJ, Sole-Lleonart C, Rello J, et al. Neumonía asociada al ventilador causada por bacterias gramnegativas multirresistentes: comprensión de la nebulización de aminoglucósidos y colistina. Cuidados Intensivos Med [Internet].2020 [citado 4 de junio del 2023], 46:766–770. Disponible en: https://doi.org/10.1007/s00134-019-05890-w

Nadeem K, Raja K, Attalla M, Patel M, Philips, M. Safety of Nebulized Colistin Solution as Adjunctive Treatment of Lower Respiratory Tract Infections. Journal of pharmacy practice, [Internet].2022 [citado 4 de junio del 2023], 35(1):75–79. Aviable in: https://doi.org/10.1177/0897190020958246

Leache L, Aquerreta I, Aldaz A, Monedero P, Idoate A, Ortega A. Effectiveness of adjunctive nebulized antibiotics in critically ill patients with respiratory tract infections. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology, [Internet].2020 [citado 4 de junio del 2023] ,39(2):361–368. Aviable in: https://doi.org/10.1007/s10096-019-03733-6